Keita Kobayashi, Hiroaki Matsumoto, Shigeru Sakano, Mitsutaka Yamamoto, Masahiro Tsuchida, Yasuhide Tei, Kazuhiro Nagao, Kazuo Oba, Seiji Kitahara, Seiji Yano, et al. Comparative Efficacy of Avelumab Maintenance Therapy Versus Continued Chemotherapy Followed by Pembrolizumab in Metastatic Urothelial Carcinoma With No Progression After 4 Cycles of Chemotherapy: A Retrospective Study Using Propensity Score Matching. Clinical Genitourinary Cancer. 2024
Kosuke Shimizu, Ryo Inoue, Shinobu Tomochika, Naohito Isoyama, Yoshiaki Yamamoto, Hiroaki Matsumoto, Koji Shiraishi, Shigefumi Yoshino, Toyonori Tsuzuki, Hideyasu Matsuyama. Mucin-producing urothelial-type adenocarcinoma of the prostate diagnosed after robot-assisted radical prostatectomy. IJU case reports. 2022. 5. 1. 32-35
Ryo Inoue, Naohito Isoyama, Sho Ozawa, Keita Kobayashi, Yoshiaki Yamamoto, Seiji Yano, Hiroshi Hirata, Hiroaki Matsumoto, Hideyasu Matsuyama. Endoscopic laser treatment for urine leakage caused by an isolated calyx after robot-assisted partial nephrectomy. IJU case reports. 2021. 4. 6. 343-346
Masahiro Samoto, Hideyasu Matsuyama, Hiroaki Matsumoto, Hiroshi Hirata, Koji Ueno, Sho Ozawa, Junichi Mori, Ryo Inoue, Seiji Yano, Yoshiaki Yamamoto, et al. Novel bone microenvironment model of castration-resistant prostate cancer with chitosan fiber matrix and osteoblasts. Oncology letters. 2021. 22. 4. 689-689
Mizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, Shintaro Narita, Yoshiaki Yamamoto, Naohiro Fujimoto, Shohei Ueda, Ario Takeuchi, Kazuyuki Numakura, Tomonori Habuchi, et al. Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer. Cancer immunology, immunotherapy : CII. 2021. 71. 3. 727-736
山本義明, 井上亮, 矢野誠司, 平田寛, 松本洋明, 恒富亮一, 藤田悠介, 大鳥徹, 松山豪泰. Pharmacogenetics-based AUC model can determine the optimal initial axitinib dose for more precise treatment of individuals with advanced renal cell carcinoma. 日本泌尿器科学会総会(Web). 2020. 108th
Clinical significance for axitinib pharmacokinetics based on the gene polymorphisms in advanced renal cell carcinoma
Japanese Journal of Clinical Medicine 2021
Prognostic biomarkers for immune checkpoint inhibitors in urothelial carcinoma
Japanese Journal of Clinical Medicine 2021
膀胱癌診療ガイドライン
医学図書出版 2019
Professional career (1):
医学博士 (山口大学大学院医学研究科)
Work history (3):
2019/04 - 現在 山口大学医学部内 併任講師
2014/04 - 2019/03 YAMAGUCHI UNIVERSITY University Hospital Assistant Professor
2011/04 - 2014/03 University of British Columbia, Vancouver Prostate Centre
2015/05 - AUA 2015 Annual Meeting, Best Poster Award
2014/11 - 第66回西日本泌尿器科学会総会学術奨励賞
2012 - 第3回 曙仁会賞 基礎論文部門
2011 - 第2回 曙仁会賞 優秀発表部門
2010 - 第1回 曙仁会賞 優秀発表部門
Show all
Association Membership(s) (9):
The Japan Endocrine Society
, American Urological Association
, 腎癌研究会
, 泌尿器分子細胞研究会
, 日本泌尿器腫瘍学会
, JAPANESE SOCIETY OF ENDOUROLOGY
, JAPAN SOCIETY OF CLINICAL ONCOLOGY
, THE JAPANESE CANCER ASSOCIATION
, THE JAPANESE UROLOGICAL ASSOCIATION